Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_assertion type Assertion NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_head.
- NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_assertion description "[Accumulating data have now identified specific genes that are commonly hypermethylated and inactivated during prostate cancer progression, including GSTpi, APC, MDR1, GPX3 and 14-3-3sigma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_provenance.
- NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_assertion evidence source_evidence_literature NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_provenance.
- NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_assertion SIO_000772 17296351 NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_provenance.
- NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_assertion wasDerivedFrom befree-20140225 NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_provenance.
- NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_assertion wasGeneratedBy ECO_0000203 NP516631.RAqfm2RNsZ-TOrkpb3x93xN2lSTNGnYpfCshYbGqwvy58130_provenance.